A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
Essen Biotech
Ipsen
Immunitas Therapeutics
Hvivo
University Hospital, Angers
Ipsen
Cyteir Therapeutics, Inc.
Celldex Therapeutics
NovalGen Ltd.
Eastern Cooperative Oncology Group
Seagen Inc.
Opna Bio LLC
GlaxoSmithKline
GlaxoSmithKline
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Scripps Health
Case Comprehensive Cancer Center